As the vibrant atmosphere of MEDICA 2023 approaches, we at Panadea Diagnostics GmbH are thrilled to announce our participation as exhibitors in one of the world's largest medical trade fairs. With a mission to revolutionize diagnostics and combat tropical and emerging infectious diseases, our journey from a spin-off of the renowned Bernhard-Nocht Institute for Tropical Medicine in Hamburg to a promising start-up has been nothing short of remarkable. In this article, we'll delve into the exciting developments surrounding our company and give you a glimpse of what to expect at our booth during the highly anticipated MEDICA 2023 expo.
"… commercially available tests – if they exist at all for the corresponding pathogens – do not always work reliably when used in endemic areas."
- Dr. Christina Deschermeier (CSO Panadea).
At the heart of our success lies our product portfolio, which focuses on ELISA assays specifically designed to detect IgG or IgM antibodies against tropical and emerging infectious disease pathogens.
These assays play a crucial role in identifying diseases caused by pathogens such as the Crimean-Congo hemorrhagic fever, Dengue and Zika viruses, and many others. By harnessing the power of state-of-the-art technology and extensive research, our team has developed highly accurate and reliable assays that enable healthcare professionals, health surveillance organisations and policy makers to make timely decisions for effective patient care and public health.
To share deep insights into our company, product pipeline, and aspirations leading up to MEDICA 2023, our Chief Scientific Officer, Dr. Christina Deschermeier had the privilege of being interviewed by Silke Meny of the MEDICA.de team. With her vast expertise and leadership, Dr. Deschermeier has been instrumental in driving our innovation and shaping the future of our company. In the interview (full interview at Panadea Diagnostics: start-up for better infection diagnostics (medica-tradefair.com)), she shed light on the following key areas:
1. Mission and Vision:
Dr. Deschermeier emphasized our commitment to making a tangible impact in the field of diagnostics. She highlighted our vision to create a healthier world by offering advanced and accessible diagnostic solutions for tropical and emerging infectious diseases.
2. Product Development:
Discussing our product pipeline, Dr. Deschermeier unveiled our ongoing efforts to expand our ELISA assay portfolio, targeting a broader range of infectious diseases. By leveraging our cutting-edge technology and close collaboration with leading research institutions, we aim to provide comprehensive diagnostic tools that can address the evolving global health challenges.
3. Collaborative Partnerships:
Dr. Deschermeier emphasized the importance of strategic collaborations with specialized institutions, especially in endemic areas. Particularly, working together with healthcare organizations, research institutes, and public health agencies enables us to accelerate the development and deployment of innovative diagnostics and contributes to the fostering of a collaborative ecosystem to combat infectious diseases effectively.
With MEDICA 2023 just around the corner, we are excited to showcase our breakthrough products and engage with medical professionals, researchers, and industry leaders from around the world.
At our set-up at the Wirtschaftsförderung und Technologietransfer Schleswig-Holstein GmbH (WTSH) booth, at position H16 in Hall 15, visitors will have the opportunity to interact with our team, grab yourself various goodies and information flyers detailing our ELISA products, and directly talk with our experts about the unique features and benefits offered by our unique spin on the traditional ELISA technology. Additionally, we will be holding slots for one-on-one discussions with our executive team, reach out to us to secure your place in advance!
We can't wait to meet you and shed light on the latest advancements in serological tests and their impact on tropical and emerging infectious diseases.
As we prepare to participate in MEDICA 2023 Expo, our team is energized by the prospect of showcasing our transformative diagnostic solutions to a global audience. With our commitment to excellence, groundbreaking research, and collaborations, we are determined to drive innovation and shape the future of diagnostics. Together, we can transcend boundaries and make significant strides in combatting tropical and emerging infectious diseases.
Join us at MEDICA 2023 Expo, and together, let's chart a path toward a healthier and more resilient world!
